The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in patients with IDA listed for OLT.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
60
see above
see above
Medical University of Vienna, Department of Surgery
Vienna, Austria
RECRUITINGHemoglobin at OLT
Change in hemoglobin concentrations from baseline until before induction of anesthesia for OLT
Time frame: 6 months
Transfusion requirement
Transfusion of PRBCs during and within the first 24 hours following OLT
Time frame: 6 months
Hemoglobin after 4 weeks
Change in hemoglobin concentrations from baseline until 4 weeks after initiation of therapy
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.